%0 Journal Article
%T Role of nanostructures in improvising oral medicine
%A Parames C. Sil
%A Shatadal Ghosh
%A Sumit Ghosh
%J Archive of "Toxicology Reports".
%D 2019
%R 10.1016/j.toxrep.2019.04.004
%K AD
%K Alzheimer¡¯s disease
%K AmB
%K amphotericin B
%K AMCNS
%K cationic niosome-based azithromycin delivery systems
%K AP
%K acetylpuerarin
%K AT1R
%K angiotensin II receptor type 1
%K BCRP
%K breast cancer resistance protein
%K CNL
%K conventional lipid nanoparticles
%K CSC
%K core shell corona nanolipoparticles
%K DCK
%K N-deoxycholyl-l-lysyl-methylester
%K DDS
%K drug delivery system
%K DM
%K diabetes mellitus
%K DOX
%K doxorubicin
%K EPR
%K enhanced permeability and retention effect
%K FRET
%K Foster resonance energy transfer
%K 5-FU
%K 5-fluorouracil
%K GI
%K gastrointestinal
%K GMO
%K glyceryl monoolein
%K IBD
%K inflammatory bowel disease
%K LG
%K Lakshadi Guggul
%K LNC
%K Lipid Nanocapsule
%K MFS
%K Miltefosine
%K MNBNC
%K Micronucleated Binucleated Cells
%K MSN
%K mesoporous silica nanoparticle
%K MTX
%K methotrexate
%K NP
%K nanoparticle
%K NPC
%K nanoparticulate carriers
%K NSAID
%K non-steroidal anti-inflammatory drug
%K OA
%K osteoarthritis
%K OXA
%K oxaliplatin
%K PAMAM
%K poly (amidoamine)
%K PD
%K Parkinson¡¯s disease
%K PEG
%K polyethylene glycol
%K PIP
%K 1-piperoylpiperidine
%K PLGA
%K polylactic-co-glycolic acid
%K PNL
%K PEGylated lipid nanoparticles
%K pSi
%K porous silicon
%K pSiO
%K porous silica oxide
%K PZQ
%K praziquantel
%K SLN
%K solid lipid nanoparticle
%K SMA
%K styrene maleic acid
%K SMEDD
%K self microemulsifying drug delivery system
%K TB
%K tuberculosis
%K Tmf
%K tamoxifen
%K TNBS
%K trinitrobenzenesulphonic acid
%K TPGS
%K tocopheryl polyethylene glycol succinate
%K WGA
%K wheat germ agglutinin Oral medicine
%K Nanostructures
%K Drug delivery system
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502743/